STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Trial details
- Registry ID
- NCT06960213
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as siRNA
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| STOP-HAE: A Phase 3 Study of ADX-324 in HAENCT06960213 | ADRX | Phase 3 | Recruiting | 2027-11-30Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |